Creating a drug's safety profile through the use of benefit-risk assessments during development.
J. Rick Turner, PhD
Advertisement
Articles by J. Rick Turner, PhD
Centralized approach for Phase III studies enhances the quality and integrity of collected data.
Advertisement
Latest Updated Articles
Integrated Drug SafetyPublished: June 1st 2011 | Updated:
The Science of Cardiac SafetyPublished: November 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Reducing Site Burden Through Better Technology Integration in Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
